Document is current
Any future updates will be listed below
-
Authors
Sajadi, Simin
Khadembashiri, Mohammad Amin
Raissi, Gholamreza
Khadembashiri, Mohamad Mehdi
Mansouri, Korosh
Hadizadeh-Kharazi, Homayoun
Joghataei, Mohammad Taghi
Madani, Seyed Pezhman
Forogh, Bijan
Parsipour, Sina
-
Clinical Trials BETA
Clinical trials referenced in this document:
irct2016021123298n3 at Iranian Registry of Clinical TrialsDocuments that mention this clinical trial
The role of adipose-derived stem cells in knee osteoarthritis treatment: insights from a triple-blind clinical study
https://doi.org/10.1186/s13287-025-04233-5
- License Information
-
More Information
Article History
Received: 21 November 2024
Accepted: 14 February 2025
First Online: 14 May 2025
Declarations
:
: We conducted this interventional triple-blind clinical trial entitled “The Effect And Safety Of Allogenic Adipose-Derived Mesenchymal Stem Cells In Treatment Of Knee Osteoarthritis, Pilot Study” after the institutional board review by Iran University of medical sciences (Ethics code number: IR.IUMS.REC.1394.26914, 24 January 2016). The ethics of this study are in accordance with the Declaration of Helsinki and its later amendments or comparable ethical standards. Trial Registry Code: IRCT2016021123298N3, 20 February 2016.
: Written informed consent was obtained from the patient for publication and any accompanying images.
: The authors declare no conflict of interest.
: The authors declare that they have not use AI-generated work in this manuscript.
